CoLabs Int’l

CoLabs Int’l

Growth Stage

Think On Your Skin, Not Through Your Skin

Think On Your Skin, Not Through Your Skin


Raised to Date: Raised: $16,250

Total Commitments ($USD)


Dalmore Group

Start Date


Close Date

Not Provided

Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common


Series A

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Reporting Date


% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Huntington Beach, California

Business Type


CoLabs Int’l is raising funds on Dalmore Group through Reg A+ crowdfunding. The company is using its innovative technology and unique absorption limiting science to reduce unwanted absorption of drugs into the skin and the environment. The Quantasphere (QS) technology of CoLabs forms a wall around an active ingredient before placing it in a formulation to create a unique delivery vessel. Laura Cohen founded CoLabs Int’l in 2008. The current crowdfunding campaign has no minimum target and a maximum target of $19,500,000. The campaign proceeds will be used for marketing, research and development, raw materials and inventory, and working capital.

Balance Sheet

Cash and Cash Equivalents


Accounts and Notes Receivable


Total Assets


Accounts Payable & Accrued Liabilities


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: Weinberg and Company, P.A.
Financials as of: 05/24/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CoLabs Int’l on Dalmore Group 2022
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $117,812,500
Price per Share: $6.50

Follow company

Follow CoLabs Int’l on Dalmore Group 2022

Buy CoLabs Int’l's Deal Report

Warning: according to the close date for this deal, CoLabs Int’l may no longer be accepting investments.

CoLabs Int’l Deal Report

Get KingsCrowd’s comprehensive report on CoLabs Int’l including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CoLabs Int’l is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CoLabs Int’l deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge